10 Trade Deadline Buyers Podcast Por  arte de portada

10 Trade Deadline Buyers

10 Trade Deadline Buyers

Escúchala gratis

Ver detalles del espectáculo

Fred Zinkie and Jeff Erickson share their Trade Deadline Buyers Preview - which 10+ teams should be buying and what are they shopping for? Who's going to end up with Luis Robert or Eugenio Suarez?

---

00:00 Trade Deadline Buyers

00:20 Welcome

00:30 Break up the Brewers

01:00 News

02:45 Tanner Scott felt something in his forearm.

05:15 Yordan Alvarez is making slow progress.

06:15 Shane McClanahan is facing a delay in his rehab assignment.

07:00 Same with Grayson Rodriguez, who is undergoing imaging on his elbow.

09:00 Shelby Miller is throwing to hitters today. He could be traded or could be the team’s closer in a couple weeks.

10:00 Adley Rutschman vs. Ivan Herrera

12:00 Sell low on Freddie Freeman?

13:45 Mookie Betts vs CJ Abrams

15:30 Josh Jung returned and homered.

18:00 NFFC

18:45 Trade Deadline Buyers Preview

19:00 What are these teams likely to acquire, and who could be bumped from their current roles?

19:30 Blue Jays: Where to add to a team that is getting average production at almost every position.

26:40 Tigers: Add CF? Closer? SP5?

30:00 Astros: Add OF? With injured SP coming back, they seem fine elsewhere.

32:00 Yankees: Prob need 2 SP and a 3B

34:45 Red Sox: SP for sure. I kind of like the lineup.

36:15 Rays: Typically, impossible to predict. Could buy and sell. Unload Littell and add someone.

39:00 Home Run Forecast

39:45 Mariners: 2B, 3B, RF.

43:45 Phillies: Closer, more than any other contender. Maybe LF too.

47:00 Mets: C, 2B, 3B.

49:30 Cubs: 3B, SP.

51:30 Brewers: I have no idea. They are similar to the Jays offensively.

53:30 Dodgers: Only RPs?

55:20 Padres: A rare team that could take an elite hitter and stick him at DH

57:25 BlueWire

57:30 Giants: SP, 1B.

Get the latest fantasy sports insights, expert analysis, and premium tools at RotoWire.com—enter promo code ROTO15 at checkout to receive 15% off any product.

Todavía no hay opiniones